Page last updated: 2024-09-04

ruboxistaurin and Weight Gain

ruboxistaurin has been researched along with Weight Gain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Brugnoli, A; Ferroni, L; Gardin, C; Ioannidi, E; Longo, F; Morari, M; Morganti, C; Nigro, F; Pavan, C; Pinton, P; Rimessi, A; Vindigni, V; Zavan, B1
Aiello, LP; Clermont, A; Della Vecchia, K; King, GL; Kondo, T; Mastumoto, M; Rask-Madsen, C; Sotiropoulos, KB; Takahashi, J; Yasuda, Y1

Other Studies

2 other study(ies) available for ruboxistaurin and Weight Gain

ArticleYear
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.
    Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2017, Volume: 42, Issue:7

    Topics: Animals; Antipsychotic Agents; Cells, Cultured; Clozapine; Drug Delivery Systems; Enzyme Inhibitors; Indoles; Male; Maleimides; Mice; Mice, Inbred C57BL; Mice, Knockout; Protein Kinase C beta; Time Factors; Weight Gain

2017
Adipose-specific effect of rosiglitazone on vascular permeability and protein kinase C activation: novel mechanism for PPARgamma agonist's effects on edema and weight gain.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2006, Volume: 20, Issue:8

    Topics: Adipose Tissue; Animals; Capillary Permeability; Diabetes Mellitus; Edema; Enzyme Activation; Enzyme Inhibitors; Hypoglycemic Agents; Indoles; Male; Maleimides; Mice; Mice, Knockout; Obesity; PPAR gamma; Protein Kinase C; Protein Kinase C beta; Rats; Rats, Zucker; Receptor, Insulin; Rosiglitazone; Thiazolidinediones; Vascular Endothelial Growth Factor A; Weight Gain

2006